Upgrade to SI Premium - Free Trial

Acumen Pharmaceuticals, Inc (ABOS)

2.24 +0.05 (2.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 4 Acumen Pharmaceuticals, For: Jun 09 Filed by: Fountain Nathan B June 10, 2026 4:51 PM - SEC Filing Form 144 Acumen Pharmaceuticals, Filed by: Fountain Nathan B June 9, 2026 4:16 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Kolchinsky Peter June 5, 2026 5:13 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Fountain Nathan B June 5, 2026 4:32 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Drapkin Kimberlee C June 5, 2026 4:32 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Stalfort John A III June 5, 2026 4:32 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Porter Derrell June 5, 2026 4:30 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Ives Jeffrey L. June 5, 2026 4:30 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Golumbeski George June 5, 2026 4:29 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Stoppel Laura June 5, 2026 4:28 PM - SEC Filing Form 8-K Acumen Pharmaceuticals, For: Jun 03 June 3, 2026 4:43 PM - SEC Filing Form 10-Q Acumen Pharmaceuticals, For: Mar 31 May 12, 2026 5:16 PM - SEC Filing Form 8-K Acumen Pharmaceuticals, For: May 12 May 12, 2026 7:08 AM - SEC Filing Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 4c May 12, 2026 7:06 AM - StreetInsider Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights May 12, 2026 7:01 AM - Globe NewsWire Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference May 7, 2026 4:00 PM - StreetInsider Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 May 5, 2026 4:00 PM - Globe NewsWire Form ARS Acumen Pharmaceuticals, For: Dec 31 April 23, 2026 7:19 PM - SEC Filing Form DEF 14A Acumen Pharmaceuticals, For: Dec 31 April 23, 2026 7:19 PM - SEC Filing Form DEFA14A Acumen Pharmaceuticals, April 23, 2026 7:19 PM - SEC Filing Form SCHEDULE 13G Acumen Pharmaceuticals, Filed by: MURRAY JAMES B JR April 7, 2026 4:07 PM - SEC Filing Form EFFECT Acumen Pharmaceuticals, April 2, 2026 6:07 AM - SEC Filing Form 424B3 Acumen Pharmaceuticals, April 1, 2026 5:16 PM - SEC Filing Acumen Pharmaceuticals, Inc (ABOS) files for 10.83M share offering by selling stockholders March 26, 2026 4:32 PM - StreetInsider Form S-3 Acumen Pharmaceuticals, March 26, 2026 4:30 PM - SEC Filing Form S-8 Acumen Pharmaceuticals, March 26, 2026 4:10 PM - SEC Filing Form 10-K Acumen Pharmaceuticals, For: Dec 31 March 26, 2026 4:08 PM - SEC Filing Stifel Reiterates Buy Rating on Acumen Pharmaceuticals, Inc. (ABOS) following in-line Q4 March 26, 2026 12:49 PM - StreetInsider Form 8-K Acumen Pharmaceuticals, For: Mar 26 March 26, 2026 7:05 AM - SEC Filing Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights March 26, 2026 7:00 AM - StreetInsider Acumen Pharmaceuticals (ABOS) Reiterated at Overweight by Cantor Fitzgerald March 26, 2026 6:56 AM - StreetInsider Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026 March 19, 2026 4:00 PM - StreetInsider Form 4 Acumen Pharmaceuticals, For: Mar 16 Filed by: Kolchinsky Peter March 18, 2026 4:16 PM - SEC Filing Form SCHEDULE 13D/A Acumen Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P. March 17, 2026 4:36 PM - SEC Filing Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s a March 17, 2026 8:02 AM - Globe NewsWire Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Pa March 17, 2026 8:00 AM - StreetInsider Acumen Pharmaceuticals, Inc. (ABOS) PT Raised to $8 at BTIG March 16, 2026 2:25 PM - StreetInsider Form 8-K Acumen Pharmaceuticals, For: Mar 13 March 16, 2026 7:02 AM - SEC Filing Acumen Pharmaceuticals raises $35.75 million in private placement March 16, 2026 6:30 AM - StreetInsider Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio March 16, 2026 6:30 AM - StreetInsider Full Article List